[Clinical Significance of Common Gene Mutations in 53 Patients with Acute Myeloid Leukemia Harboring 11q23/MLL Rearrangements].

Shu-Xiao Bai,Yan-Lei Gong,Jing-Ren Zhang,Chun-Xiao Wu,Jun Zhang,Hui-Ying Qiu,Hong-Jie Shen,Jian-Nong Cen,Su-Ning Chen,Jin-Lan Pan

DOI: https://doi.org/10.19746/j.cnki.issn.1009-2137.2020.03.001

2020-01-01

Abstract:A relatively high mutation frequency is observed in AML patients with 11q23/MLL rearrangements and most cases shows single mutation. The RAS signaling pathway alterations are most common. Gene mutation does not affect the OS of these patients, who show poor prognosis. A significantly higher Hb at initial diagnosis in FLT3 mutated patients is significantly higher than that in FLT3 wild-type cases. Patients who underwent HSCT show a better prognosis than those only received chemotherapy.